Guselkumab (Tremfya; Johnson & Johnson) continued to reduce signs and symptoms of active psoriatic arthritis (PsA) and ...

At the Institute for Value-Based Medicine ® event in New Orleans, Louisiana, on November 4, Clark Alsfeld, MD, a hematology ...

Diet and wellness impact multiple sclerosis management, enhancing quality of life and reducing fatigue through lifestyle ...

Current NCCN Guidelines recommend molecular testing for patients with follicular lymphoma, which has improved diagnostic ...

While next-generation sequencing (NGS) has become routine in academic settings, its use for patients with follicular lymphoma ...

Approximately 1 in 30 trials were disrupted by research grant terminations at the National Institutes of Health (NIH) earlier ...

For the conclusion to this 4-part video series, tune in to learn the lessons each organization will carry forward from this ...

Rural primary care is strained by clinician shortages, limited access, and financial instability, impacting health outcomes and increasing emergency department reliance. National initiatives like the ...

Using chronological age cut-offs—such as 60 years—to divide patients with acute myeloid leukemia (AML) for clinical trials ...

Ryan Haumschild, PharmD, MS, MBA, introduces the faculty and sets the agenda to explore disease background, novel therapies, ...

Ryan Haumschild, PharmD, MS, MBA, introduces the faculty and sets the agenda to explore disease background, novel therapies, ...

Panelists discuss how structured, multidisciplinary screening efforts can catch MASH earlier and prevent progression.